quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:16·18d
SECFiling
Nkarta Inc. logo

SEC Form EFFECT filed by Nkarta Inc.

NKTX· Nkarta Inc.
Health Care
Original source

Companies

  • NKTX
    Nkarta Inc.
    Health Care

Recent analyst ratings

  • May 15UpdateWilliam Blair-
  • Oct 9UpdateRodman & Renshaw$14.00
  • Aug 14UpdateRaymond James$16.00
  • Mar 22UpdateRaymond James$16.00
  • Dec 22UpdateOppenheimer-
  • Oct 10UpdateCanaccord Genuity$25.00

Related

  • SEC20h
    SEC Form DEFA14A filed by Nkarta Inc.
  • SEC20h
    SEC Form DEF 14A filed by Nkarta Inc.
  • PR8d
    Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
  • PR15d
    Nkarta to Participate in Needham Virtual Healthcare Conference
  • SEC20d
    SEC Form 424B5 filed by Nkarta Inc.
  • SEC29d
    SEC Form S-3 filed by Nkarta Inc.
  • SEC29d
    SEC Form 10-K filed by Nkarta Inc.
  • SEC29d
    Nkarta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022